186 related articles for article (PubMed ID: 24379900)
1. NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice.
Hernandes MS; Café-Mendes CC; Britto LR
Oxid Med Cell Longev; 2013; 2013():157857. PubMed ID: 24379900
[TBL] [Abstract][Full Text] [Related]
2. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
[TBL] [Abstract][Full Text] [Related]
3. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
[TBL] [Abstract][Full Text] [Related]
4. Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.
Zhang W; Yan ZF; Gao JH; Sun L; Huang XY; Liu Z; Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Hu Y; Wang F; Hong JS; Wang XM
Mol Neurobiol; 2014 Jun; 49(3):1153-65. PubMed ID: 24277523
[TBL] [Abstract][Full Text] [Related]
5. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Zn
Tamano H; Nishio R; Morioka H; Takeda A
Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
[TBL] [Abstract][Full Text] [Related]
7. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
[TBL] [Abstract][Full Text] [Related]
8. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
9. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.
Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J
J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107
[TBL] [Abstract][Full Text] [Related]
10. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
11. Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.
Deng Y; Jiao C; Mi C; Xu B; Li Y; Wang F; Liu W; Xu Z
Mol Neurobiol; 2015 Feb; 51(1):68-88. PubMed ID: 24969583
[TBL] [Abstract][Full Text] [Related]
12. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation.
Hou L; Zhang C; Wang K; Liu X; Wang H; Che Y; Sun F; Zhou X; Zhao X; Wang Q
Toxicology; 2017 Apr; 380():1-10. PubMed ID: 28202386
[TBL] [Abstract][Full Text] [Related]
13. Double-stranded RNA-induced dopaminergic neuronal loss in the substantia nigra in the presence of Mac1 receptor.
Xu W; Wang Y; Quan H; Liu D; Zhang H; Qi Y; Li Q; Liao J; Gao HM; Zhou H; Huang J
Biochem Biophys Res Commun; 2020 Dec; 533(4):1148-1154. PubMed ID: 33046245
[TBL] [Abstract][Full Text] [Related]
14. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.
Rodrigues RW; Gomide VC; Chadi G
Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344
[TBL] [Abstract][Full Text] [Related]
15. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.
Qin L; Liu Y; Hong JS; Crews FT
Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1.
Zhang FL; He Y; Zheng Y; Zhang WJ; Wang Q; Jia YJ; Song HL; An HT; Zhang HB; Qian YJ; Tong YL; Dong L; Wang XM
CNS Neurosci Ther; 2014 Dec; 20(12):1036-44. PubMed ID: 25399812
[TBL] [Abstract][Full Text] [Related]
18. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
Xu X; Song N; Wang R; Jiang H; Xie J
Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
[TBL] [Abstract][Full Text] [Related]
19. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
[TBL] [Abstract][Full Text] [Related]
20. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
Silva C; Fuxe K; Chadi G
J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
